A5082587391- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Genital Health and Disease
- Renal cell carcinoma treatment
- Urinary Tract Infections Management
- Renal and related cancers
- Renal and Vascular Pathologies
- Maternal and fetal healthcare
- Ureteral procedures and complications
- Urological Disorders and Treatments
- MRI in cancer diagnosis
- Bacterial Identification and Susceptibility Testing
- Bladder and Urothelial Cancer Treatments
- Pelvic and Acetabular Injuries
- Biliary and Gastrointestinal Fistulas
- Inflammatory Biomarkers in Disease Prognosis
- Global Cancer Incidence and Screening
- Infectious Disease Case Reports and Treatments
- Urologic and reproductive health conditions
- Kidney Stones and Urolithiasis Treatments
- Pediatric Urology and Nephrology Studies
- Viral-associated cancers and disorders
- Molecular Biology Techniques and Applications
Monash Health
2023-2025
Monash University
2023-2024
Vita-Salute San Raffaele University
2023
Austin Health
2017-2022
The University of Melbourne
2017-2022
Austin Hospital
2019
Abstract Backgrounds PSA screening is advocated in men with a life expectancy of >10 years. With rising mean 81 years Australia, many their 70s have expectancies Additionally, advanced age an independent risk factor for high grade prostate cancer. Hence, we aimed to identify patient and disease characteristics outcomes >70 undergoing transperineal biopsies (TPB) suspected Methods All patients aged 70 old above who underwent TPB cancer between 1st January 2019 July 2022 at large...
847 Background: Intravesical Bacillus Calmette–Guérin (BCG) remains the gold standard for management of high-grade non-muscle invasive bladder cancer (NMIBC). However, up to 70% patients fail BCG therapy. We aimed define potential mechanisms resistance and develop an immunohistochemical (IHC) panel help identify likely respond intravesical BCG. Methods: Patients with NMIBC undergoing induction at a tertiary institution were identified. Twelve BCG-responders 13 non-responders matched patient...
Abstract Objectives To compare the outcomes between re‐induction Bacillus Calmette‐Guérin (BCG) and sequential intravesical gemcitabine‐docetaxel (Gem/Doce) therapy in patients with high‐grade (HG) non‐muscle invasive bladder cancer (NMIBC) following failure of initial induction BCG. Materials methods We retrospectively identified who received BCG 2017 2023. Inclusion criteria were NMIBC recurrence post‐BCG induction, subsequent treatment by either or Gem/Doce. Results From to 2023, 140 BCG,...
Objective To describe our technique, illustrated with images and videos, of robot‐assisted partial nephrectomy ( RAPN ) for challenging renal tumours. Patients Methods A study 249 patients who underwent in multiple institutions was performed. were identified using prospective databases. Complex lesion defined as those a RENAL nephrometry score ≥10. Data analysed differences among groups examined. Results total 31 (12.4%) s performed complex The median (interquartile range [ IQR ]) patient...
To compare the accuracy of European Randomized Study Screening for Prostate Cancer (ERSPC) RC, MRI-ERSPC-RC, and Biopsy Collaborative Group (PBCG) RC in patients undergoing transperineal prostate biopsy.We identified 392 who underwent mpMRI before biopsy across multiple public private institutions between January 2017 August 2019. The estimated probabilities detecting PCa significant were calculated using ERSPC-RC, PBCG-RC. Receiver operating characteristic (ROC) curves each calculator...
Abstract Background From 1 July 2018, the Australian Medicare Benefits Schedule (MBS) introduced rebates for multi‐parametric magnetic resonance imaging (mpMRI) workup prostate cancer (PCa). We aimed to determine if subsidisation of mpMRI prior transperineal biopsy altered our institution's practice patterns and outcomes. Methods All patients who underwent at an tertiary institution from January 2017 2020 were identified. Patients with known PCa excluded. stratified into two groups: a...
We wished to compare the efficacy of ultrasound versus intravenous contrast-enhanced computed tomography (CT) for detecting recurrent renal cell carcinoma (RCC) by identifying patients presenting with such tumor burden and evaluate utility these imaging modalities in circumstances.Patients who developed local and/or distant recurrences following surgical intervention RCC were identified. The regimen utilized during post-operative surveillance was analyzed determine whether disease...
Abstract Objectives The objectives of this study are as follows: to assess the uropathogen antibiogram at two tertiary hospitals in Victoria look difference susceptibility patterns, whether national guideline recommendations were applicable and feasibility local analysis guide development hospital‐specific guidelines for empirical treatment urosepsis pre‐operative prophylaxis urological procedures. Patients methods All positive urine cultures analysed Barwon Health Monash Health, regional...
Objective To assess changes in diagnosis prostate cancer (PCa) grade, biopsy and treatment approach over a decade (2011–2020) at population level within clinical quality registry. Patients Methods diagnosed by between 2011 2020 were retrieved from the Victorian Prostate Cancer Outcomes Registry, prospective, state‐wide registry Australia. Distributions of each grade group (GG) proportion time modelled with restricted cubic splines, separately technique, age subsequent method. Results From to...